If you have searched "Eargo Canada" or wondered whether Eargo's invisible in-canal hearing devices are the right call for a Canadian buyer, this guide is for you. Eargo is a real, well-known American hearing brand. It is also a brand that has gone through significant corporate change in the past two years, which matters more than it sounds when you are a Canadian buying a device that you may need to return, repair, or replace at some point in the next three years.
We sell a competing product line, so weigh the bias accordingly. We have tried to keep this comparison honest and factual.
The short version
Eargo makes premium, invisible, in-canal OTC hearing aids designed and sold primarily for the U.S. market. The brand was taken private by Patient Square Capital in January 2024 and, in April 2025, merged with hearX (the parent of Lexie) to form a new combined company called LXE Hearing. The parent now operates both the Eargo and Lexie brands under one roof.
HearHelp is a Canadian personal sound amplifier (PSAP) brand. Two products — Active at $399 CAD and Clarity at $549 CAD — with same-currency pricing, free Canada-wide shipping, Canadian support, and a 45-day risk-free trial.
The two are not direct equivalents in either price or regulatory category, but they show up in the same search results because they target the same kind of customer: someone who wants help hearing better without going through a clinical hearing aid fitting. This guide walks through how they compare, what Eargo's corporate changes mean for Canadian buyers, and which option fits which situation.
Eargo's recent history (the facts)
This part matters because reasonable buyers worry about it, and we would rather give you the actual facts than let you piece it together from second-hand sources.
2010-2022. Eargo founded in 2010, went public on Nasdaq in October 2020, became a well-known U.S. brand in the direct-to-consumer hearing space.
2022. Eargo agreed to a $34.37 million settlement with the U.S. Department of Justice over allegations that it submitted hearing aid reimbursement claims to the Federal Employees Health Benefits Program with unsupported hearing-loss diagnosis codes. Eargo denied the allegations as part of the settlement. The settlement effectively ended Eargo's U.S. federal-program revenue stream and triggered significant financial distress.
Late 2022. Patient Square Capital, a healthcare-focused investment firm, became Eargo's majority shareholder.
October 2023 - January 2024. Patient Square Capital agreed to acquire all remaining outstanding Eargo shares and take the company private at $2.55 per share — a 52 percent premium to the prior closing price, but a fraction of Eargo's IPO valuation. The take-private deal closed in January 2024 and Eargo was delisted from Nasdaq (hearingtracker.com).
April 2025. Eargo and hearX (the South African / U.S. health-tech company behind Lexie Hearing) completed a merger, forming a new combined company called LXE Hearing. Patient Square Capital invested an additional $100 million into the combined company. Eargo and Lexie continue to operate as distinct brands under the LXE Hearing parent (patientsquarecapital.com).
To be clear: Eargo did not file for bankruptcy. It went private and was subsequently merged into a larger combined entity. The brand continues to sell its product line, including the Eargo 7 and the newer Eargo 8 launched in late 2025. Whether the merger ultimately strengthens or complicates Eargo's customer support remains to be seen.
What does this mean for Canadian buyers?
A few practical implications.
The brand is in transition, not in failure. Eargo continues to make and sell products. If you order an Eargo device today, you will receive it. The product itself is well-engineered — Eargo's invisible-in-canal design with flexible silicone fibres has been respected in the industry for years.
Customer support is being reorganised. When two companies merge, support teams, return processes, and warranty handling typically get restructured over 12 to 24 months. This is normal corporate behaviour. It does mean that the person you spoke to in 2023 may not be the person who answers in 2026, and the return process may not be identical to what it was at the time of your original purchase.
Eargo is still U.S.-focused. Eargo's marketing, distribution, customer service, and return logistics are built for the American market. They do ship to Canada, but Canadian buyers have always been an afterthought rather than a strategic focus. The merger does not change that — if anything, the priority is consolidating U.S. operations with Lexie.
Eargo is an OTC hearing aid in the U.S., not a PSAP. Eargo 7 is FDA 510(k)-cleared as a self-fitting OTC hearing aid (the U.S. medical device category). In Canada, the OTC hearing aid category does not exist, so the regulatory framing is more ambiguous. The device functions similarly to a high-end PSAP for the buyer's purposes, but it is technically positioned differently.
Side-by-side comparison
| Dimension | HearHelp Active | HearHelp Clarity | Eargo (current line) |
|---|---|---|---|
| Price (Canadian buyer all-in) | $399 CAD | $549 CAD | Approx. $2,000-$3,500 CAD-equivalent |
| Regulatory category | PSAP (consumer electronics) | PSAP (consumer electronics) | US OTC hearing aid (medical device) |
| Form factor | TWS earbud | Behind-the-ear / RIE | Completely-in-canal (invisible) |
| Rechargeable | Yes | Yes | Yes |
| Smartphone app | Yes | Yes | Yes |
| Trial period | 45 days | 45 days | 45 days (US terms) |
| Free shipping | Yes (Canada-wide) | Yes (Canada-wide) | US-origin; varies |
| Currency at checkout | CAD | CAD | USD |
| Canadian return path | Domestic | Domestic | Cross-border |
| Support timezone | Canadian | Canadian | US |
| Corporate parent | HearHelp (Canada) | HearHelp (Canada) | LXE Hearing (US, PE-backed) |
A few notes. Eargo's price range above reflects the all-in cost for a Canadian buyer including currency conversion, shipping, and any potential cross-border fees — not the sticker price advertised in U.S. dollars on Eargo's American site. Eargo is priced in the same general band as prescription hearing aids, which is by design: it is positioned as a premium OTC option in the U.S. market, not as a budget alternative.
Why an in-Canada brand matters for warranty and returns
This is the dimension that the U.S. brands tend to underplay and that we tend to emphasise — because we think it is the most underappreciated part of the buying decision.
When you buy a device from a Canadian brand, the warranty and return path is entirely domestic. If the device develops a fault in month seven, you call a Canadian phone number, talk to someone in Canadian business hours, and ship the device to a Canadian address with a domestic shipping label. The replacement comes back to you in a week or so. The whole loop is measured in days.
When you buy from a U.S. brand and need a warranty repair from Canada, the loop runs across the border in both directions. Your defective device gets shipped to a U.S. address (return shipping often at your cost), gets inspected, and a replacement is shipped back. Customs paperwork has to be filed correctly on both legs to avoid the device getting held up or assessed for duties on re-entry. The whole loop can take three to six weeks if things go smoothly, and longer if anything gets stuck.
For an inexpensive product, that friction is annoying but bearable. For a device that costs $2,000 or more and that you depend on to participate in family dinners, that friction is genuinely consequential.
The same logic applies to returns within the trial window. Both Eargo and HearHelp advertise 45-day trials. But "45 days to send it back to Canada" and "45 days to send it back to the United States" are not the same thing in practice. The cross-border return is more expensive, takes longer, and creates more opportunities for something to go wrong.
Where Eargo wins
We want to be fair about this. There are buyers for whom Eargo is the right answer.
Cosmetic invisibility. Eargo's completely-in-canal design is genuinely invisible at conversational distance. No PSAP we know of can match that — including ours. If a device being visible is a deal-breaker for you, Eargo's form factor is its strongest argument.
OTC hearing aid regulatory status (in the U.S.). Eargo 7 and 8 are FDA-cleared OTC hearing aids, which means they have met the FDA's labelling, performance, and output limit requirements for that category. In the U.S., this gives buyers some additional regulatory assurance that PSAPs do not provide. In Canada, that distinction does not carry the same legal weight because we do not have an equivalent OTC category, but it still reflects the underlying engineering rigour.
Brand recognition. Eargo has spent more on advertising and direct response than most of its competitors combined. If you have heard of the brand and built up some sense of legitimacy from that exposure, that is a real signal even if it is not a direct product feature.
Mature product line. The current Eargo line is the seventh and eighth generations. The fit, comfort, and audio tuning have been refined over many iterations. New entrants are still doing that work.
Where HearHelp wins
Price. $399 CAD for the Active and $549 CAD for the Clarity. Eargo's CAD-equivalent prices run several times higher. For someone whose hearing changes are mild-to-moderate and situational, paying premium-OTC pricing is hard to justify.
Same-currency pricing, Canadian shipping, Canadian returns. Discussed above. This is the dimension where every comparison between HearHelp and a U.S. brand comes out the same way, because the underlying friction is structural rather than something the U.S. brand can fix without setting up Canadian operations.
45-day trial that returns to Canada. Our pricing page lays out the terms. Domestic return shipping, full refund, no restocking fees.
Two products, clearly differentiated. The Active is the discreet daily option; the Clarity is the higher-amplification behind-the-ear option. We do not need eight near-identical SKUs to make the catalogue look bigger. Our device choice guide walks through which one fits which use case.
No corporate restructuring overhang. We are a Canadian company focused on the Canadian PSAP market. Our priorities are clear and our support operation is not currently being merged with another company's. That is not a guarantee of permanence — businesses change — but it is a different kind of stability than a brand that has just been through a take-private and a merger in 24 months.
Which is the right call for you?
Choose Eargo if: you want a U.S. OTC hearing aid with maximum cosmetic invisibility, you are comfortable paying $2,000+ CAD-equivalent for the device, you have no issue with cross-border purchases and returns, and brand recognition matters to you.
Choose HearHelp Active ($399 CAD) if: you want a discreet, low-friction Canadian purchase for daily situational listening — restaurants, dinners, family conversation — at a price that does not require you to commit thousands of dollars up front.
Choose HearHelp Clarity ($549 CAD) if: you want more amplification headroom and a stable behind-the-ear / receiver-in-ear fit, particularly for demanding listening situations like large group dinners or sermons.
Choose neither, and book an audiology appointment, if: your hearing situation actually calls for clinical fitting. Sudden hearing change, asymmetric loss, severe loss, tinnitus that started recently, ear pain, or dizziness all warrant a professional assessment rather than a consumer-electronics purchase. The Canadian Hard of Hearing Association is a good starting point for finding services. Our PSAP vs hearing aid guide walks through exactly when to make that call.
Frequently asked questions
Is Eargo still in business?
Yes. Eargo continues to operate as a brand under the LXE Hearing umbrella following the April 2025 merger with hearX (Lexie's parent company). Patient Square Capital provided $100 million in additional funding at the time of the merger. Eargo launched the Eargo 8 in late 2025. Buying an Eargo device today is not the same as buying from a company that is going out of business — it is buying from a brand that is in the middle of a significant corporate transition.
Does Eargo ship to Canada?
Yes, Eargo ships to Canadian addresses, but the brand is U.S.-focused. Pricing is in U.S. dollars, support runs on U.S. business hours, returns ship to a U.S. address, and warranty replacements run across the border. None of those are deal-breakers, but they are real friction points that Canadian-based brands do not have.
Why is Eargo so much more expensive than a PSAP?
Eargo is regulated and priced as an OTC hearing aid in the U.S. — a medical device category with FDA labelling, performance, and output-limit requirements. PSAPs are consumer electronics with no medical device regulation. Some of the price difference reflects the regulatory and engineering rigour; some of it reflects the brand's premium positioning. Whether you need the medical device categorisation depends on your situation. The Johns Hopkins overview of OTC hearing aids is a useful primer on what the FDA category actually requires (hopkinsmedicine.org).
What happened to Eargo's invisible-in-canal design — is it still available?
Yes. Eargo's signature completely-in-canal design with flexible silicone Flexi Fibres continues across the current product line. The Eargo 7 and the newer Eargo 8 maintain that form factor. If invisible-in-canal is a deal-breaker preference for you, Eargo is one of very few options that delivers it at this level of polish.
Will my Eargo warranty still be honoured after the LXE Hearing merger?
Eargo has continued to honour existing warranties through the corporate changes, based on public statements. Corporate transitions can complicate the practical experience of filing a warranty claim — phone numbers change, return addresses get updated, support staff turn over — but the legal warranty obligation typically transfers with the brand. If you already own an Eargo device and are concerned, contact their current support directly to confirm your warranty status and the current return address before you need it.
HearHelp sells personal sound amplifiers, not medical devices, and we do not diagnose or treat hearing loss. For an overview of how PSAPs differ from prescription hearing aids in Canada, see our PSAP vs hearing aids breakdown, or browse the broader 2026 PSAP round-up to see how Eargo compares against other options. To start a 45-day trial of either HearHelp model, visit our pricing page.